Journal of Receptors and Signal Transduction · 1995 · 43 citations · 17 references
MedicineMolecular BiologyPharmacologyMolecular PharmacologyNeuropharmacologySignal TransductionDopaminergic PharmacologyDopaminergic SignalingLigand BindingNeurotransmissionReceptor BindingReceptor PharmacologyAdenylate Cyclase RegulationAdenylate Cyclase SignalingAdenylyl Cyclase RegulationClozapine PharmacologyDopamine D2-like ReceptorsDopamine Receptor SubtypesHaloperidol PharmacologyReceptors
The D2 dopamine receptor is known to be functionally coupled to the inhibition of adenylate cyclase when expressed in a number of mammalian cell lines. However, functional coupling of the recently discovered D3 and D4 dopamine receptor subtypes has been more difficult to demonstrate. In this study, human D2, D3 and D4 receptors were stably expressed separately in human embryonic kidney cells (HEK 293). In these cells, activation of D2, D3 or D4 receptors resulted in the inhibition of forskolin-stimulated adenylate cyclase activity in a dose responsive manner. This activation was prevented by pre-incubation of the cells expressing these receptors with the dopaminergic antagonist haloperidol. Radioligand binding studies using [3H]spiperone confirmed that the atypical neuroleptic clozapine has higher affinity for the human D4 receptor than the D3 or D4 receptors, although only 6-fold higher than the D2 receptor in this study. In addition, ribonuclease protection studies demonstrated the presence of D4 dopamine receptor mRNA in human brain regions.
17
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1
Roger K. Sunahara, Hong‐Chang Guan, Brian F. O’Dowd et al. · Nature · 1991 · 1.2K citations · Full text
Cloning and expression of a rat D2 dopamine receptor cDNA
James R. Bunzow, Hubert H.M. Van Tol, David K. Grandy et al. · Nature · 1988 · 1.1K citations